Literature DB >> 11558570

Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17.

T Niwa1, M Fujimoto, K Kishimoto, Y Yabusaki, F Ishibashi, M Katagiri.   

Abstract

The metabolism of bisphenol A (BPA) was determined for 11 forms of human hepatic cytochromes P450 (CYPs) expressed in the yeast Saccharomyces cerevisiae and for human steroidogenic CYP17 expressed in Escherichia coli. Additionally, the effect of BPA on the progesterone 17alpha-chydroxylase activity of CYP17 was investigated. CYP2C18 catalyzed BPA metabolism most efficiently, followed by CYP2C19 and CYP2C9. CYP2C9 and CYP2C18 exhibited the highest affinity (Km=3.9 microM) for BPA metabolism. The Vmax of CYP2C18 (8.10 nmol x min(-1) x nmol CYP(-1)) was 5 times higher than that of CYP2C9. Although the Vmax of CYP2C19 was 1.5 times higher than that of CYP2C18, the affinity of CYP2C19 was 12 times lower than that of CYP2C9 and CYP2C18. Therefore the intrinsic clearance (Vmax/Km) of CYP2C18 was more than 5 times higher than that of CYP2C9 and CYP2C19. On the other hand, BPA exhibited a competitive-type inhibition of the progesterone 17alpha-hydroxylase activity of CYP17 with a Ki value of 71 microM, whereas no metabolism of BPA by CYP17 was detected. These results suggest that BPA is mainly metabolized by the CYP2C subfamily in human liver, and that BPA inhibits human steroidogenic CYP17 activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11558570     DOI: 10.1248/bpb.24.1064

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  16 in total

Review 1.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing.

Authors:  Jian Zhu-Ge; Ying-Nian Yu; Yu-Li Qian; Xin Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Hepatic Detoxification of Bisphenol A is Retinoid-Dependent.

Authors:  Igor O Shmarakov; Vira L Borschovetska; William S Blaner
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

5.  Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut.

Authors:  Shinji Ito; Chi Chen; Junko Satoh; Sunhee Yim; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  Bisphenol F Exposure in Adolescent Heterogeneous Stock Rats Affects Growth and Adiposity.

Authors:  Valerie A Wagner; Karen C Clark; Leslie Carrillo-Sáenz; Katie A Holl; Miriam Velez-Bermudez; Derek Simonsen; Justin L Grobe; Kai Wang; Andrew Thurman; Leah C Solberg Woods; Hans-Joachim Lehmler; Anne E Kwitek
Journal:  Toxicol Sci       Date:  2021-05-27       Impact factor: 4.849

7.  Defined plant extracts can protect human cells against combined xenobiotic effects.

Authors:  Céline Gasnier; Claire Laurant; Cécile Decroix-Laporte; Robin Mesnage; Emilie Clair; Carine Travert; Gilles-Eric Séralini
Journal:  J Occup Med Toxicol       Date:  2011-01-20       Impact factor: 2.646

8.  Bisphenol A and hormone-associated cancers: current progress and perspectives.

Authors:  Hui Gao; Bao-Jun Yang; Nan Li; Li-Min Feng; Xiao-Yu Shi; Wei-Hong Zhao; Si-Jin Liu
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  The Association of Serum Bisphenol A with Thyroid Autoimmunity.

Authors:  La-Or Chailurkit; Wichai Aekplakorn; Boonsong Ongphiphadhanakul
Journal:  Int J Environ Res Public Health       Date:  2016-11-17       Impact factor: 3.390

10.  Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity.

Authors:  Ming Li; Yunjia Yang; Yi Yang; Jie Yin; Jing Zhang; Yixing Feng; Bing Shao
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.